(S)-4-(2-Hydroxyethyl)-2,2-dimethyl-1,3-dioxolane>95.0%(GC)1g

Ethyl 3-bromo-5-fluorobenzoate, 98%, 25g

(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97%, 25g

ETHYL 1-(6-AMINO-3,5-DIFLUOROPYRIDIN-2-YL)-6,7-DIFLUORO-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLATE, 95.0%, 1g

2-(3-Chloro-phenyl)-oxirane, 97.0%, 1g

5-Chloro-2-(trifluoromethyl)benzamide, 10g

3-(3,5-Difluorophenyl)acrylic acid, 98%, 100g

Methyl 5-phenylnicotinate, 98%, 5g

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 95+%, 5g

4-Methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-N-(p-tolyl)aniline, 98%, 1g

tert-Butyl 2'-(methylthio)-6'-oxo-5'-(((trifluoromethyl)sulfonyl)oxy)-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylate, 97%, 50mg

3-Iodopyridin-4-ol, 95.0%, 100g

Methyl 3-Methoxysalicylate>98.0%(GC)5g